Cargando…
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
22q11.2 deletion syndrome (22q11.2DS) is the most common human chromosomal microdeletion, causing developmentally linked congenital malformations, thymic hypoplasia, hypoparathyroidism, and/or cardiac defects. Thymic hypoplasia leads to T cell lymphopenia, which most often results in mild SCID. Desp...
Autores principales: | Bhalla, Pratibha, Du, Qiumei, Kumar, Ashwani, Xing, Chao, Moses, Angela, Dozmorov, Igor, Wysocki, Christian A., Cleaver, Ondine B., Pirolli, Timothy J., Markert, Mary Louise, de la Morena, Maria Teresa, Baldini, Antonio, van Oers, Nicolai S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663160/ https://www.ncbi.nlm.nih.gov/pubmed/36136514 http://dx.doi.org/10.1172/JCI160101 |
Ejemplares similares
-
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
por: Bhalla, Pratibha, et al.
Publicado: (2023) -
Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models
por: Bhalla, Pratibha, et al.
Publicado: (2020) -
The Genetics and Epigenetics of 22q11.2 Deletion Syndrome
por: Du, Qiumei, et al.
Publicado: (2020) -
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development
por: Mustillo, Peter J., et al.
Publicado: (2023) -
The 22q11.2 Deletion Syndrome: A Gene Dosage Perspective
por: Baldini, Antonio
Publicado: (2006)